255 related articles for article (PubMed ID: 21165995)
41. Retrospective study on the effects of lipiodolization before a potentially curative hepatectomy for colorectal liver metastases: long-term results of a pilot study.
Utsunomiya T; Emi Y; Ikejiri K; Suzuki M; Saitsu H; Yakabe S; Nonaka M; Saku M; Yoshida K; Shimada M; Sugimachi K
Hepatogastroenterology; 2001; 48(39):790-3. PubMed ID: 11462925
[TBL] [Abstract][Full Text] [Related]
42. Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases.
Aloia T; Sebagh M; Plasse M; Karam V; Lévi F; Giacchetti S; Azoulay D; Bismuth H; Castaing D; Adam R
J Clin Oncol; 2006 Nov; 24(31):4983-90. PubMed ID: 17075116
[TBL] [Abstract][Full Text] [Related]
43. [Treatment of patients with liver metastases from colorectal cancer. More patients can benefit from the treatment!].
Lindnér P; Cahlin C; Friman S; Hafström L; Rizell M; Olausson M
Lakartidningen; 2003 Aug; 100(35):2684-8. PubMed ID: 14531128
[TBL] [Abstract][Full Text] [Related]
44. [Hepatic resection after neoadjuvant therapy for initially unresectable colorectal liver metastases].
Kaibori M; Iwamoto S; Ishizaki M; Matsui K; Saito T; Yoshioka K; Kwon AH
Gan To Kagaku Ryoho; 2009 Dec; 36(13):2579-82. PubMed ID: 20009458
[TBL] [Abstract][Full Text] [Related]
45. Neoadjuvant chemotherapy for patients with liver metastases from colorectal cancer.
Mandalà M; Mosconi S; Quadri A; Milesi L; Labianca R
Expert Rev Anticancer Ther; 2007 Jun; 7(6):887-97. PubMed ID: 17555399
[TBL] [Abstract][Full Text] [Related]
46. [Process in surgical exeresis of colorectal cancer liver metastases].
Jaeck D; Bachellier P; Weber JC; Oussoultzoglou E; Greget M
Bull Acad Natl Med; 2003; 187(5):863-76; discussion 876-9. PubMed ID: 14979052
[TBL] [Abstract][Full Text] [Related]
47. The role of chemotherapy in the curative treatment of patients with liver metastases from colorectal cancer.
Leichman L
Surg Oncol Clin N Am; 2007 Jul; 16(3):537-56, viii-ix. PubMed ID: 17606193
[TBL] [Abstract][Full Text] [Related]
48. Reduction of nonresectable liver metastasis from colorectal cancer after oxaliplatin chemotherapy.
Bismuth H; Adam R
Semin Oncol; 1998 Apr; 25(2 Suppl 5):40-6. PubMed ID: 9609107
[TBL] [Abstract][Full Text] [Related]
49. [Regional adjuvant therapy in colorectal liver metastases: requirements for clinical therapy studies from the statistical viewpoint].
Müller HH; Schäfer H
Zentralbl Chir; 1995; 120(10):755-9. PubMed ID: 7502588
[TBL] [Abstract][Full Text] [Related]
50. [Actual achievements in the therapy of hepatic metastases in patients with colorectal cancer].
Heinemann V; Löhe F
MMW Fortschr Med; 2009 Jan; 151(5):35-7. PubMed ID: 19391410
[No Abstract] [Full Text] [Related]
51. Neoadjuvant chemotherapy and resection for initially irresectable colorectal liver metastases.
Capussotti L; Muratore A; Mulas MM; Massucco P; Aglietta M
Br J Surg; 2006 Aug; 93(8):1001-6. PubMed ID: 16739103
[TBL] [Abstract][Full Text] [Related]
52. An update on chemotherapy of colorectal liver metastases.
Wang CC; Li J
World J Gastroenterol; 2012 Jan; 18(1):25-33. PubMed ID: 22228967
[TBL] [Abstract][Full Text] [Related]
53. [Colorectal cancer].
Oya M; Sameshima S; Tagaya N; Takeshita E; Koketsu S; Sugamata Y; Yoshiba H; Ueno M; Fujimoto Y; Suenaga M
Gan To Kagaku Ryoho; 2011 Aug; 38(8):1252-5. PubMed ID: 21829061
[TBL] [Abstract][Full Text] [Related]
54. Optimal indication criteria for neoadjuvant chemotherapy in patients with resectable colorectal liver metastases.
Ichida H; Mise Y; Ito H; Ishizawa T; Inoue Y; Takahashi Y; Shinozaki E; Yamaguchi K; Saiura A
World J Surg Oncol; 2019 Jun; 17(1):100. PubMed ID: 31196104
[TBL] [Abstract][Full Text] [Related]
55. Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases.
Pulitanò C; Aldrighetti L; Arru M; Vitali G; Ronzoni M; Catena M; Finazzi R; Villa E; Ferla G
Ann Surg; 2006 Nov; 244(5):833-5; author reply 835. PubMed ID: 17060779
[No Abstract] [Full Text] [Related]
56. Neoadjuvant chemotherapy for resectable colorectal liver metastases: what is the evidence? Results of a systematic review of comparative studies.
Nigri G; Petrucciani N; Ferla F; La Torre M; Aurello P; Ramacciato G
Surgeon; 2015 Apr; 13(2):83-90. PubMed ID: 25257725
[TBL] [Abstract][Full Text] [Related]
57. Neoadjuvant treatment before resection of liver metastases.
Benoist S; Nordlinger B
Eur J Surg Oncol; 2007 Dec; 33 Suppl 2():S35-41. PubMed ID: 17981428
[TBL] [Abstract][Full Text] [Related]
58. [Disputes about surgical treatment of colorectal liver metastasis].
Lin JZ; Pan ZZ
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Aug; 16(8):714-7. PubMed ID: 23980037
[TBL] [Abstract][Full Text] [Related]
59. The role of biological agents in the resection of colorectal liver metastases.
Nordlinger B; Adam R; Arnold D; Zalcberg JR; Gruenberger T
Clin Oncol (R Coll Radiol); 2012 Aug; 24(6):432-42. PubMed ID: 22794325
[TBL] [Abstract][Full Text] [Related]
60. Surgical results after downstaging of initially marginal or non-resectable liver metastases.
Cauchy F; Faivre S; Belghiti J
Dig Dis; 2012; 30 Suppl 2():143-9. PubMed ID: 23207947
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
